EZH2 mutations arise almost exclusively in Germinal Center (GC) subtype DLBCL, being present in 22% of GC-DLBCL [4], and represent gain-of-function mutations which occur mostly at hotspot Y641 [5,6,7]. Here, EZH2 is linked to diffuse large B-cell lymphoma.